María Magdalena Gherardi

Biology of Attenuated Modified Vaccinia Virus Ankara Recombinant Vector in Mice: Virus Fate and Activation of B- and T-Cell Immune Responses in Comparison with the Western Reserve Strain and Advantages as a Vaccine

Juan Camilo Ramírez, María Magdalena Gherardi, Mariano Estéban · Journal of Virology · 2000 · 217 citations

Life Sciences, Immunology, Infectious Diseases +17

Interleukin-12 (IL-12) Enhancement of the Cellular Immune Response against Human Immunodeficiency Virus Type 1 Env Antigen in a DNA Prime/Vaccinia Virus Boost Vaccine Regimen Is Time and Dose Dependent: Suppressive Effects of IL-12 Boost Are Mediated by Nitric Oxide

María Magdalena Gherardi, Juan Camilo Ramírez, Mariano Estéban · Journal of Virology · 2000 · 108 citations

Life Sciences, Immunology, Infectious Diseases +15

Attenuated Modified Vaccinia Virus Ankara Can Be Used as an Immunizing Agent under Conditions of Preexisting Immunity to the Vector

Juan Camilo Ramírez, María Magdalena Gherardi, Dolores Rodrı́guez et al. · Journal of Virology · 2000 · 90 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Cellular and Biochemical Differences between Two Attenuated Poxvirus Vaccine Candidates (MVA and NYVAC) and Role of the C7L Gene

José Luis Nájera, Carmen Gómez, Elena Domingo-Gil et al. · Journal of Virology · 2006 · 82 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

IL-12 Delivery from Recombinant Vaccinia Virus Attenuates the Vector and Enhances the Cellular Immune Response Against HIV-1 Env in a Dose-Dependent Manner

María Magdalena Gherardi, Juan Camilo Ramírez, Dolores Rodrı́guez et al. · The Journal of Immunology · 1999 · 74 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17